Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 5 Schemes (0.99%)
Foreign Institutions
Held by 6 Foreign Institutions (1.54%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2024)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
USD 84 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.57
-999,999.00%
2.37






